| scholarly article | Q13442814 |
| P356 | DOI | 10.2147/IJWH.S8548 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC2971727 |
| https://europepmc.org/articles/PMC2971727?pdf=render | ||
| https://www.dovepress.com/getfile.php?fileID=6327 | ||
| P932 | PMC publication ID | 2971727 |
| P698 | PubMed publication ID | 21072301 |
| P5875 | ResearchGate publication ID | 47756205 |
| P50 | author | Tim Reynolds | Q39051936 |
| P2860 | cites work | Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 |
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Down's syndrome screening is unethical: views of today's research ethics committees | Q35094059 | ||
| Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 | ||
| First trimester Down syndrome screening: public health implications | Q36232101 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Prenatal diagnosis: progress through plasma nucleic acids | Q36673937 | ||
| The ethics of antenatal screening: lessons from Canute. | Q37470283 | ||
| Human genetic improvement: a comparison of Russian and British public perceptions. | Q53446275 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) | Q57839618 | ||
| Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening | Q57917224 | ||
| Practical and theoretical implications of fetal-maternal lymphocyte transfer | Q70109256 | ||
| Prenatal screening for Down's syndrome using inhibin-A as a serum marker | Q71124683 | ||
| Fetal cells in maternal blood. Overview and historical perspective | Q72764144 | ||
| New strategy for prenatal diagnosis of X-linked disorders | Q74053620 | ||
| A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A | Q77790082 | ||
| Accuracy of Down's syndrome risks produced in a prenatal screening program | Q77887852 | ||
| Integrated screening for Down's syndrome based on tests performed during the first and second trimesters | Q78109767 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Screening for Down syndrome: changing practice of obstetricians | Q39992814 | ||
| Selective abortion: a new moral order? Consensus and debate in the medical community | Q41005147 | ||
| Decisions about prenatal testing for chromosomal disorders: perceptions of a diverse group of pregnant women | Q41739512 | ||
| Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months | Q43251635 | ||
| The perceptions of Lutheran pastors toward prenatal genetic counseling and pastoral care | Q45304997 | ||
| Reactions to prenatal testing: reflection of religiosity and attitudes toward abortion and people with disabilities | Q45865429 | ||
| Physicians' acceptability of termination of pregnancy after prenatal diagnosis in southern France | Q45884151 | ||
| Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences | Q46840808 | ||
| Second-trimester Down's syndrome serum screening: double, triple or quadruple marker testing? | Q47298639 | ||
| Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight | Q47417242 | ||
| Practical and ethical considerations of noninvasive prenatal diagnosis. | Q51933954 | ||
| Serum screening for Down's syndrome. | Q52391580 | ||
| The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. | Q52474421 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Down syndrome | Q47715 |
| congenital onset | Q21953121 | ||
| P304 | page(s) | 83-88 | |
| P577 | publication date | 2010-08-09 | |
| P1433 | published in | International Journal of Women's Health | Q6051629 |
| P1476 | title | The triple test as a screening technique for Down syndrome: reliability and relevance | |
| P478 | volume | 2 |
| Q51411648 | Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group. |
| Q41900060 | Down syndrome and consanguinity |
| Q48287894 | Down syndrome: the brain in trisomic mode |
| Q35528950 | Extragonadal actions of chorionic gonadotropin |
| Q85944128 | Genetic screening services provided in Turkey |
| Q36335133 | Non-Invasive Screening Tools for Down's Syndrome: A Review |
| Q26783426 | Noninvasive prenatal diagnosis |
| Q38067242 | Prognostic models in the clinical arena |
| Q35877443 | Retrospective study evaluating the performance of a first-trimester combined screening for trisomy 21 in an Italian unselected population. |
Search more.